Howard Hughes Medical Institute’s Elevance Health ELV Stock Holding History

Howard Hughes Medical Institute’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48	Closed	-$16.8K	–	180
2025 Q4	$16.8K	Sell	48 -1	-2%	-$338	0.01%	131
2025 Q3	$15.8K	Sell	49 -1	-2%	-$311	0.01%	142
2025 Q2	$19.4K	Buy	+50	New	+$20.1K	0.01%	114
2016 Q3	–	Sell	-7,404	Closed	-$972K	–	158
2016 Q2	$972K	Sell	7,404 -1,902	-20%	-$260K	0.33%	68
2016 Q1	$1.29M	Buy	9,306 +1,637	+21%	+$219K	0.29%	58
2015 Q4	$1.07M	Buy	7,669 +5,083	+197%	+$700K	0.16%	70
2015 Q3	$362K	Buy	+2,586	New	+$389K	0.07%	103
2015 Q2	–	Sell	-1,661	Closed	-$256K	–	167
2015 Q1	$256K	Buy	1,661 +608	+58%	+$86.6K	0.03%	119
2014 Q4	$132K	Buy	1,053 +329	+45%	+$40.7K	0.04%	136
2014 Q3	$87K	Buy	+724	New	+$83K	0.02%	146

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Howard Hughes Medical Institute's ELV Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 48 shares — an estimated $16.8K sold.

Howard Hughes Medical Institute first reported a position in ELV in Q3 2014 and held it in 10 quarters. The position peaked at $1.29M in Q1 2016. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 48 Elevance Health shares in Q1 2026, an estimated $16.8K.
Howard Hughes Medical Institute first reported a position in Elevance Health in Q3 2014 and held it in 10 quarters.
Howard Hughes Medical Institute's Elevance Health position peaked at $1.29M in Q1 2016.
1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.